Malpractice Challenge In $50M Eli Lilly Settlement Stands
A former plaintiff in a $50 million settlement over claims that Eli Lilly & Co's Zyprexa drug gave patients diabetes can pursue malpractice claims against a firm he says didn't have...To view the full article, register now.
Already a subscriber? Click here to view full article